Search

everythinglearnresearchcommunity

for

Search:↓

ALRV5XR significantly improves hair density in women with hair loss and is well-tolerated.

Baricitinib is generally safe for long-term use in treating severe alopecia areata.

Topical treatment SM04554 safely promotes hair growth in male baldness.

Scalp medⓇ effectively and safely improves hair growth in men with androgenetic alopecia.

The trial will test if proxalutamide is safe and effective in reducing death in severe COVID-19 patients.

Finasteride safety data in trials may be underreported or misrepresented.

ALRV5XR effectively increases hair density in men with androgenetic alopecia without adverse effects.

Baricitinib is a safe and effective treatment for severe alopecia areata.

CTP-543 is generally safe for treating alopecia areata.

CAP7.1 is generally safe at 200 mg/m²/day, but can cause fatigue, nausea, hair loss, fever, and blood-related issues.

Tavaborole is a safe and effective toenail fungus treatment, with the 5% solution being the best option.

Epirubicin and cyclophosphamide cause more anemia and side effects than docetaxel and cyclophosphamide, but both are equally effective.

Panax ginseng is generally safe with mild side effects and may have health benefits, but more research is needed.

Tralokinumab for atopic dermatitis may cause side effects like dizziness, headache, nausea, hair loss, and acne.

The Exfoliate-Dissolve-Repair skincare approach may effectively treat keratosis pilaris and reduce the need for corticosteroids.

The Ayurvedic treatment improved hair growth and reduced hair loss safely.

Combining laser therapy with minoxidil improves hair growth and satisfaction without extra side effects.

Ritlecitinib is generally safe for alopecia areata patients over 72 months.

BLH308, with persimmon leaf, green tea, and sophora fruit extracts, safely increased hair density and thickness.

The hair growth serum was tested for safety and if it works in people with hair loss and for healthier hair.

Ritlecitinib is generally safe for adolescents with alopecia areata over 5 years.

MK-0773 safely increased muscle mass but did not improve muscle strength or function in elderly women with sarcopenia.

Deuruxolitinib effectively promotes hair regrowth in adults with alopecia areata.

Ritlecitinib effectively regrows hair in adolescents with alopecia areata and is safe.

The treatment improved hair growth in people with male pattern baldness.

Inconsistent safety reporting in chronic back pain trials risks patient safety and decision-making.

LB-P9 supplements improve hair health and satisfaction without side effects.

Ritlecitinib is effective and safe for hair regrowth in Asian patients with alopecia areata.

Ritlecitinib is being tested for safety and effectiveness in young children with severe alopecia areata.

0.5% minoxidil mesotherapy is more effective and safe for hair growth in women with androgenetic alopecia than topical 2% minoxidil.